Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Beadle

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|January 28, 2005
Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitroWilliam B Wan, James R Beadle, Caroll Hartline, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 17, 2014
Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery systemFeiyan Ma, Kaihui Nan, SuNa Lee, et al.
Drug Delivery|November 9, 2017
A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferationMei Chen, Jiangping Hou, Guilin Tan, et al.
American Journal of Obstetrics and Gynecology|July 22, 2020
Improving management of the genitourinary syndrome of menopause: evaluation of a health system-based, cluster-randomized interventionKimberly K Vesco, Michael C Leo, Joanna E Bulkley, et al.
Antiviral Research|August 21, 2003
Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidneyStephanie L Ciesla, Julissa Trahan, W Brad Wan, et al.
Journal of Medicinal Chemistry|March 17, 2006
Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxvirusesJames R Beadle, William B Wan, Stephanie L Ciesla, et al.
Antiviral Research|November 25, 2006
Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in miceKarl Y Hostetler, James R Beadle, Julissa Trahan, et al.
Bioorganic & Medicinal Chemistry|July 2, 2011
Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replicationNadejda Valiaeva, David L Wyles, Robert T Schooley, et al.
Antiviral Research|March 21, 2007
Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovirJacqueline C Ruiz, James R Beadle, Kathy A Aldern, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 29, 2007
Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pigAjay M Tammewar, Lingyun Cheng, Karl Y Hostetler, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|January 28, 2005
Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitroWilliam B Wan, James R Beadle, Caroll Hartline, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 17, 2014
Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery systemFeiyan Ma, Kaihui Nan, SuNa Lee, et al.
Drug Delivery|November 9, 2017
A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferationMei Chen, Jiangping Hou, Guilin Tan, et al.
American Journal of Obstetrics and Gynecology|July 22, 2020
Improving management of the genitourinary syndrome of menopause: evaluation of a health system-based, cluster-randomized interventionKimberly K Vesco, Michael C Leo, Joanna E Bulkley, et al.
Antiviral Research|August 21, 2003
Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidneyStephanie L Ciesla, Julissa Trahan, W Brad Wan, et al.
Journal of Medicinal Chemistry|March 17, 2006
Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxvirusesJames R Beadle, William B Wan, Stephanie L Ciesla, et al.
Antiviral Research|November 25, 2006
Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in miceKarl Y Hostetler, James R Beadle, Julissa Trahan, et al.
Bioorganic & Medicinal Chemistry|July 2, 2011
Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replicationNadejda Valiaeva, David L Wyles, Robert T Schooley, et al.
Antiviral Research|March 21, 2007
Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovirJacqueline C Ruiz, James R Beadle, Kathy A Aldern, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 29, 2007
Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pigAjay M Tammewar, Lingyun Cheng, Karl Y Hostetler, et al.
Pageof 9